Abstract

Objective Triptolide is the major active component of Tripterygium wilfordii Hook. f., which has been used as an anti-inflammatory agent in traditional Chinese medicine for centuries. The mechanisms of the anti-inflammatory effects of triptolide in renal diseases are not well understood. Recent studies have shown that overexpression of monocyte chemoattractant protein-1 in renal tubular epithelial cells is associated with the inflammatory injuries of renal tubulointerstitium. In this study, we investigated the effect of triptolide on the overexpression of monocyte chemoattractant protein-1 in renal tubular epithelial cells in vitro. Methods Human proximal tubular epithelial cells were treated with gamma interferon (200 μg/L) and tumor necrosis factor-alpha (20 μg/L) or combined with different concentrates of triptolide (0.4, 2, 10 μg/L) for 12 hours (for monocyte chemoattractant protein-1 mRNA measuring) or 24 hours (for monocyte chemoattractant protein-1 protein measuring). The expression of monocyte chemoattractant protein-1 mRNA was detected by using reverse transcriptase-polymerase chain reaction. The expression of monocyte chemoattractant protein-1 protein in the cells was measured by using flow cytometry. Monocyte chemoattractant protein-1 levels in the supernatant were measured by using the enzyme-linked immunosorbent assay method. Results After treatment with interferon-γ and tumor necrosis factor-α, monocyte chemoattractant protein-1 mRNA and protein levels in human proximal tubular epithelial cells and monocyte chemoattractant protein-1 concentrations in the supernatant were significantly increased. Triptolide (10 μg/L) can significantly inhibit the overexpression of monocyte chemoattractant protein-1 mRNA and protein in human proximal tubular epithelial cells. The increase of monocyte chemoattractant protein-1 protein in the supernatant was also markedly inhibited by triptolide (2, 10 μg/L). Conclusion The results of this study suggest that the inhibition of monocyte chemoattractant protein-1 overexpression in tubular epithelial cells may contribute to the anti-inflammatory effects of triptolide in renal diseases.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.